Works matching IS 01986325 AND DT 2024 AND VI 44 AND IP 6
Results: 16
Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2545, doi. 10.1002/med.22050
- By:
- Publication type:
- Article
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2640, doi. 10.1002/med.22049
- By:
- Publication type:
- Article
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2510, doi. 10.1002/med.22048
- By:
- Publication type:
- Article
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2472, doi. 10.1002/med.22047
- By:
- Publication type:
- Article
Engineering peptide drug therapeutics through chemical conjugation and implication in clinics.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2420, doi. 10.1002/med.22046
- By:
- Publication type:
- Article
Front Cover Image, Volume 44, Issue 6.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. i, doi. 10.1002/med.22089
- By:
- Publication type:
- Article
Inside Front Cover Image, Volume 44, Issue 6.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. ii, doi. 10.1002/med.22088
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2363, doi. 10.1002/med.22087
- Publication type:
- Article
OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2825, doi. 10.1002/med.22068
- By:
- Publication type:
- Article
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2793, doi. 10.1002/med.22064
- By:
- Publication type:
- Article
The antisickling agent, 5‐hydroxymethyl‐2‐furfural: Other potential pharmacological applications.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2707, doi. 10.1002/med.22062
- By:
- Publication type:
- Article
Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2624, doi. 10.1002/med.22060
- By:
- Publication type:
- Article
Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2730, doi. 10.1002/med.22059
- By:
- Publication type:
- Article
Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2774, doi. 10.1002/med.22058
- By:
- Publication type:
- Article
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2600, doi. 10.1002/med.22057
- By:
- Publication type:
- Article
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment.
- Published in:
- Medicinal Research Reviews, 2024, v. 44, n. 6, p. 2367, doi. 10.1002/med.22045
- By:
- Publication type:
- Article